Fundraising FoxThird Rock Ventures — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
Fulcrum Therapeutics develops small-molecule drugs targeting rare genetic diseases with significant unmet treatment needs, with its lead candidate pociredir in clinical testing for sickle cell disease as an oral therapy designed to increase fetal hemoglobin levels.
BiotechCambridge, US
Robert Gould(Executive Officer, Director)inAlex C. Sapir(President and Chief Executive Officer, Director)in
BoardAlan Ezekowitz(Director)inJames Geraghty(Director)James Collins(Director)
Board seatMark Levin· per SEC Form D
Co-investorsForesite CapitalSanofi Ventures
Element Science is a medical technology company that develops the Jewel, an FDA-approved adhesive-based wearable cardioverter defibrillator designed to protect patients at risk of sudden cardiac arrest.
AI & Machine LearningDigital HealthHardwareHealthtechMedical DevicesSan Francisco, US
Uday N. Kumar(Executive Officer, Director)inUday Kumar(Founder)in
BoardRussell Hirsch(Director)Krishna Yeshwant(Director)inWilliam H. Kucheman(Director)
Board seatNeil Exter· per SEC Form D
Co-investorsGV (Google Ventures)Deerfield Management CompanyQiming Venture Partners
Imaginab develops advanced imaging solutions for immuno-oncology that visualize immune cell activity and treatment response without invasive biopsies.
BiotechHealthtechMedical DevicesInglewood, US
Anna M. Wu(Executive Officer, Director)Jeffrey D. Quan(Executive Officer)Benjamin Chen(Executive Officer)inJennifer Keppler(President and Chief Operating Officer)Christian Behrenbruch(Chief Executive Officer)
BoardIsaac Bright(Director)
Board seatAbbie Celniker· per SEC Form D · $9.5M raise · filed Apr 2016
Co-investorsCycad Group LLCRaptor Group
BiotechCambridge, US
Richard Gaynor, M.D.(Executive Officer)inRobert Ang, M.D.(Executive Officer)Yasir Al-Wakeel(Executive Officer)inEric Lander(Director)Hugh Dowd(Executive Officer, Director)
BoardCary Pfeffer, M.D.(Director)
Board seatRobert KamenRobert Tepper· per SEC Form D
Co-investorsNextech InvestSofinnova VenturesClal Biotechnology IndustriesWellington Management
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.